AHAbigail G. Harrell

Abigail G. Harrell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abigail G. Harrell has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Particle Shape Modulates the Function of Adoptive Macrophage Transfers

    by Matthew M. C. Kwan, Nicole B. Day, Iain R. Konigsberg, Evan Thoresen, Abigail G. Harrell, Celeste E. Busch, Elizabeth J. Davidson, Ivana V. Yang, C. Wyatt Shields

    Adoptive cell transfers (ACTs) constitute an emerging platform for improving the systemic delivery of nano‐ and microparticle systems. Macrophages (Mφ) are an attractive cell type for particle‐carrying ACTs because their attachment, phagocytosis, and chemotaxis can improve pharmacokinetics and reduce off‐target effects. However, little is known about how macrophage transport and function change when carrying particles of different shapes, or whether these changes can be leveraged for improving ACTs. This work investigates macrophage interactions with biodegradable spherical and discoidal particles to promote or suppress phagocytosis, respectively. Adoptively transferred macrophages with internalized spheres (Mφ‐S) or surface‐bound discs (Mφ‐D) possess enhanced targeted delivery to solid tumors compared to conventional free microparticle administration by 5.2‐fold and exhibit distinct phenotypic profiles within the cold B16‐F10 tumor microenvironment. Moreover, phenotypic changes are evaluated upon particle association by profiling the transcriptional, chromatin accessibility, and protein state. Mφ‐S complexes adopt epigenetic changes and key biomarkers associated with a proinflammatory phenotype. In Mφ‐D complexes, a diverse chromatin and protein landscape with simultaneous upregulation of both pro‐ and anti‐inflammatory biomarkers is observed, suggesting functional flexibility is observed. These findings suggest particle shape can be used as a design parameter to influence the function of adoptive macrophage transfers without compromising their delivery performance.


  • Open Access

    Dissolved gases from pressure changes in the lungs elicit an immune response in human peripheral blood

    by Abigail G. Harrell, Stephen R. Thom, C. Wyatt Shields

    Conventional dogma suggests that decompression sickness (DCS) is caused by nitrogen bubble nucleation in the blood vessels and/or tissues; however, the abundance of bubbles does not correlate with DCS severity. Since immune cells respond to chemical and environmental cues, we hypothesized that the elevated partial pressures of dissolved gases drive aberrant immune cell phenotypes in the alveolar vasculature. To test this hypothesis, we measured immune responses within human lung‐on‐a‐chip devices established with primary alveolar cells and microvascular cells. Devices were pressurized to 1.0 or 3.5 atm and surrounded by normal alveolar air or oxygen‐reduced air. Phenotyping of neutrophils, monocytes, and dendritic cells as well as multiplexed ELISA revealed that immune responses occur within 1 h and that normal alveolar air (i.e., hyperbaric oxygen and nitrogen) confer greater immune activation. This work strongly suggests innate immune cell reactions initiated at elevated partial pressures contribute to the etiology of DCS.